Daniel Neumeier, PhD, is an Associate Director of Business Development at pharma&, where they lead strategic value creation across the pharma BD lifecycle, focusing on the hemato-oncology portfolio. Their background includes a PhD from ETH Zürich, where they published extensively on preclinical antibody discovery. Additionally, they have experience in patent law and management consulting, having contributed to significant due diligence and strategic assessments in the life sciences sector. Currently, they are also pursuing a Financial Modeling and Valuation Analyst certificate from the Corporate Finance Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices